SCHEMBL1030447

SCHEMBL1030447

NC(=O)c1cccc(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.52
AURKA O14965 2/20 0.52
TTK P33981 2/20 0.52
AURKB Q96GD4 2/20 0.52
INCENP Q9NQS7 2/20 0.52
GSK3B P49841 2/20 0.51
MAPK8 P45983 2/20 0.51
PIK3CG P48736 1/20 0.51
CAMKK2 Q96RR4 1/20 0.51
HDAC6 Q9UBN7 2/20 0.50
FAAH O00519 2/20 0.50
TRPA1 O75762 1/20 0.50
EPHX2 P34913 1/20 0.50
FAAH2 Q6GMR7 1/20 0.50
MGLL Q99685 1/20 0.50
DGAT1 O75907 1/20 0.50
CCNB2 O95067 2/20 0.49
CDK1 P06493 2/20 0.49
CCNB1 P14635 2/20 0.49
CCNB3 Q8WWL7 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034808 0.86 AURKA (0.55) AURKATTKAURKBINCENPMAPK8
SCHEMBL1034911 0.85 ROCK2 (0.57) AURKATTKAURKBINCENPGSK3B
SCHEMBL1033696 0.84 MTOR (0.61) AURKATTKAURKBINCENPGSK3B
SCHEMBL1033626 0.83 CDK1 (0.53) MAPK14AURKATTKAURKBINCENP
SCHEMBL6107613 0.83 MAPK14 (0.47) MAPK14AURKATTKAURKBINCENP
SCHEMBL3619159 0.81 ADORA1 (0.59) GSK3BMAPK8HDAC6DGAT1CCNB2
SCHEMBL1028968 0.81 MAP4K4 (0.55) AURKATTKAURKBINCENPGSK3B
SCHEMBL1030530 0.81 ADORA1 (0.59) GSK3BMAPK8HDAC6DGAT1CCNB2
SCHEMBL1032453 0.80 ABL1 (0.66) AURKATTKAURKBINCENPGSK3B
SCHEMBL1033479 0.78 PTGS2 (0.55) AURKATTKAURKBINCENPGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed